Replies to post #63413 on Biotech Values

[DewDiligence]

MNTA insider sale:

Director and co-founder Robert Langer sold 20K shares @16.81 last Friday (Aug 8). This represents approximately 2% of Langer’s pre-sale holding of 970,000 shares. (Langer also owns approximately 100,000 options.)

http://sec.gov/Archives/edgar/data/1235010/000117911008015051/xslF345X03/edgar.xml

[DewDiligence]

MNTA Insider Shareholdings

[Updated for SEC filings through 8/11/08.]

 
 Executive Officers  
 Craig Wheeler, CEO         350K shares   475K options 
 G. Venkataraman, CSO       458K shares   145K options 
 Steven Brugger, COO        263K shares   168K options 
 *John Bishop, SVP Pharma    39K shares   166K options 
 †Bruce Leicher, Gen Counsel   0 shares      0 options 
 ‡James Roach, CMO             0 shares   163K options 
 Richard Shea, CFO           28K shares   208K options 
 -- 
 Six executive officers   1,138K shares 1,325K options

 
 Non-executive directors  
 Peter Barrett (Atlas)    2,459K shares    96K options 
 John Clarke                 77K shares    96K options 
 Alan Crane (Polaris)       586K shares    74K options 
 Marsha Fanucci                0 shares    96K options 
 Peter Hutt                  67K shares   176K options 
 Robert Langer              950K shares    96K options 
 *Ram Sasisekharan          406K shares    96K options 
 *Bennett Shapiro             5K shares   124K options 
 Elizabeth Stoner              0 shares    49K options 
 **James Sulat                 0 shares      0 options 
 -- 
 10 non-executive dirctrs 4,550K shares   903K options

 
 All officers/directors   5,688K shares 2,228K options 
  
 *10b5-1 selling plan in effect. 
 **Elected to BoD 6/5/08. 
 †Hired 7/24/08. 
 ‡Hired 2/26/08.